Blackfly Investments, LLC – Trademark Portfolio
Entity Type: 16
Blackfly Investments, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include CANNAGX and CANNACOGENETICS. The owner is based in Vancouver, WA.
14401 SE First Street
Vancouver, WA 98684
Showing of trademarks Trademarks
Trademark Classifications
Blackfly Investments, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Blackfly Investments, LLC have?
Blackfly Investments, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 3 abandoned, 3 cancelled.
What trademark classes does Blackfly Investments, LLC file in?
Blackfly Investments, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Blackfly Investments, LLC's most well-known trademarks?
Blackfly Investments, LLC's registered trademark portfolio includes well-known marks such as CANNAGX and CANNACOGENETICS. These are among 2 currently registered trademarks in the portfolio.
What is Blackfly Investments, LLC's trademark registration success rate?
Blackfly Investments, LLC has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 1 application is pending review.